StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -CN¥33.08M. The highest annual figure on record is -CN¥33.08M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥33.08M–
FY2024Dec 31, 2024-CN¥305.36M–
FY2023Dec 31, 2023-CN¥535.92M–
FY2022Dec 31, 2022-CN¥856.31M–
FY2021Dec 31, 2021-CN¥749.30M–
FY2020Dec 31, 2020-CN¥379.10M–
FY2019Dec 31, 2019-CN¥137.73M–
FY2018Dec 31, 2018-CN¥136.72M–

More Burning Rock Biotech figures

See a number that looks wrong?